Estimating the reliability of individual predictions is key to increase the adoption of computational models and 'artificial intelligence' in preclinical drug discovery, as well as to foster its application to guide decision making in clinical settings. Among the large number of algorithms developed over the last decades to compute prediction errors, Conformal Prediction (CP) has gained increasing attention in the computational drug discovery community. A major reason for its recent popularity is the ease of interpretation of the computed prediction errors in both classification and regression tasks. For instance, at a confidence level of 90% the true value will be within the predicted confidence intervals in at least 90% of the cases. This so called validity of conformal predictors is guaranteed by the robust mathematical foundation underlying CP. The versatility of CP relies on its minimal computational footprint, as it can be easily coupled to any machine learning algorithm at little computational cost. In this review, we summarize underlying concepts and practical applications of CP with a particular focus on virtual screening and activity modelling, and list open source implementations of relevant software. Finally, we describe the current limitations in the field, and provide a perspective on future opportunities for CP in preclinical and clinical drug discovery.
Introduction
A major research area in machine learning is the development of algorithms to compute the reliability of individual predictions. Such reliability estimates are essential to increase the trust and application of artificial intelligence solutions to guide decision making, especially in the context of healthcare and personalized medicine, where correctly identifying e.g., which patients are likely to benefit from a particular drug treatment has strong ethical and legal implications 1 .
Estimating the reliability of predictive models is of particular relevance in drug discovery, where both the prediction and the associated uncertainty need to be taken into account for decision making 2 . The set of molecules for which a model is expected to generate reliable predictions is termed the applicability domain of a model 3 . Therefore, the development of algorithms to define and compute the applicability domain of predictive models has been an area of intense research in preclinical drug discovery, and due to the amount of recent research in the field we will in the following often focus on virtual screening in particular [4] [5] [6] [7] .
The generation of a predictive model, such as a Quantitative-Structure Activity Relationship (QSAR) model, or any other property model, consists of encoding the set of molecules for which the variable of interest has been experimentally measured (e.g., in vitro potency; the dependent or response variable) using numerical descriptors (covariates or independent variables) [8] [9] [10] .
Subsequently, the covariates are related to the response variable using a mathematical model, which can be simple (e.g., multiple linear regression) or complex, such as Random Forests (RF), Support Vector Machines (SVM) or Deep Neural Networks, which might consist of thousands to millions of parameters 11 . These models are then used to predict the activity or property of interest for untested molecules in silico to prioritize for further experimental testing those with higher chances of being active. Although a plethora of algorithmically diverse approaches to encode chemical structures and to relate these to a dependent variable of interest have been developed over the last decades 10, 12 , all depend on the limited amount of data available for training. This is key to drug discovery, as the amount and diversity of the training data (in this case chemical compounds) limits the set of small molecules to which a given model can be applied and give reasonable results. In practice usually more (and more homogenous) data is available in early-stage settings (such as hit discovery), and less so in later (such as in vivo) stages, making early stage model generation generally speaking relatively easier than late-stage models. However, what is generally applicable and a key question is how to assign the confidence, reliability, or applicability domain of a model, and while quantitatively models in different stages might have larger or smaller applicability domains its importance is universal.
Widely-used algorithms to generate QSAR models, such as Support Vector Machines (SVM) or Random Forest (RF), output a single value (regression) or label (classification) for new instances [13] [14] [15] . In practice, the lack of uncertainty estimates for point or single-class predictions hampers the use of computational models to guide prospective screening experiments in earlystage drug discovery, given that 'desired' values of an output variable may well be associated with high uncertainty (and vice versa), but this will not be explicitly communicated to the user by the algorithm. However, in the same way experiments need to be repeated in order to assign both a measurement and its standard deviation of a variable, also computational predictions need to output the expectation value of the model and an associated confidence interval.
We note that there exist algorithms whose outputs are well-calibrated probability distributions rather than point predictions, e.g., Gaussian Processes (GP) [16] [17] [18] [19] or Dropout Neural Networks 20, 21 . However, these are generally computationally intense (e.g., GP training requires the inversion of the covariance matrix, which drastically increases their computational footprint), require the optimization of a large number of parameters, as well as prior knowledge about these 19 . Hence, most applications in the medicinal chemistry literature use alternative algorithms (e.g., RF), which are faster to train (by e.g., parallelizing the training phase), and require less parameter optimization 22, 23 . Therefore, much effort has been invested in the community to develop uncertainty estimation methods that could be easily adapted to algorithms used in practice 22, [24] [25] [26] [27] .
To date, a plethora of diverse algorithms have been developed to define the applicability domain of virtual screening models 3, 5, 7, 10, 12, 17, 18, 22, 24, 25, [28] [29] [30] [31] [32] [33] . Overall, existing methods harness the distance in descriptor space of new instances to those in the training set 25, 34 , or intrinsic information derived from the models (e.g., bagged variance, which is positively correlated with high average error in prediction 22, 35 ) , to identify areas in chemical space underrepresented in the training data for which the models are unlikely to deliver reliable predictions. The performance of these approaches is generally quantified by testing whether the error in prediction increases as a function of the distance of the test molecules to those in the training data 34 . However, such correlations do not guarantee that the predictions are well-calibrated, i.e., the fraction of instances whose true value lies within the predicted error interval is not guaranteed to be proportional to a user-defined tolerated error rate.
One method which has recently gained a lot of attention to address this problem is Conformal Prediction (CP; Table 1 ) [36] [37] [38] . CP is a mathematical framework to generate confidence predictors to model the reliability of predictions in diverse tasks, from property modelling to multi-target drug design (Table 2) . A confidence predictor is a type of predictor that guarantees that the true value will be within the predicted confidence region (in regression) or within a set of predicted labels (in the case of classification) at a given confidence level (CL). For instance, at a confidence level of 80%, the confidence intervals computed using a valid Conformal Predictor in a regression setting would contain the true value in at least 80% of the cases ( Figure 1a ). In classification tasks, the set of predicted classes for new instances will contain the true label in at least 80% of the cases. The prediction of well-calibrated (or valid) confidence regions by CP, which is usually not the case for other modelling methods, guarantees a lower bound for validation rates, and permits to limit the number of false positives, thus increasing the retrieval rate of active compounds in preclinical drug discovery 39 . The confidence level is commonly set at 0.80, as this confidence level represents a generally suitable trade-off between efficiency and validity (note that a CL of 80% is also reported as 0.80 in the CP literature) 40 . The validity of CP holds if the randomness assumption is fulfilled, i.e., the training instances are representative of those to which the models will be applied; or, in other words, that the data are independent and identically distributed (i.i.d.). In practice, CP are also valid if the slightly weaker assumption of exchangeability is fulfilled, which assumes that the datapoints do not follow any particular order even if they are not i.i.d 36, 39 . Although the exchangeability principle is generally assumed to hold when modelling preclinical data 32, 36, 37 , the authors have shown that this is not always the case in virtual iterative screening experiments using QSAR data sets (Figure 1b ) 41 . Overall, CP does not introduce more assumptions than those generally made when modelling bioactivity data.
To generate errors associated with predictions, Conformal Predictors evaluate the 'nonconformity' of a new instance to those used during training by applying a new non-conformity measure. Intuitively, the non-conformity measure quantifies how different a given instance is from those already seen during the training phase, which is quantified using a non-conformity score (a). Therefore, any metric quantifying the applicability domain of a model, e.g., the distance of a new instance to the training set, can be used as non-conformity measure. The simplest non-conformity measure in a regression setting would be the unsigned error in prediction computed for e.g., the instances or the hold-out folds in cross-validation. In classification tasks, non-conformity scores are generally computed using a class probability estimation method; for instance, the fraction of trees in a RF model voting for a particular class, the distance to the cut-off value or hyperplane that separates classes in the case of e.g., SVM
( Table 2 ). Note that the selection of a non-conformity measure usually exploits information already provided by the underlying algorithm. For instance, in the case of RF models the fraction of Trees voting for each class in classification, of the bagged variance in regression, are often used as non-conformity measures.
A second key aspect to consider is the efficiency of CP (Table 1) . In regression, the efficiency of a Conformal Predictor is determined by the size of the predicted confidence regions. Even if a Conformal Predictor may be valid, it might not be useful in practice to guide decision making if the confidence regions span several bioactivity units 40, 42 . In classification, efficiency is related to the fraction of single-class predictions that are correct 38, 43 .
In addition to the features listed above, Conformal Prediction can be used in combination with any machine learning algorithm 32, 37 , requires minimal computational cost beyond the training of the underlying algorithm 32 , and no parameterization is required except for the selection of a non-1 -error rate Figure 1 . (a) Example of a calibration plot for a well-calibrated Regression Conformal Predictor (adapted from 41 ). Calibration plots represent the fraction of confidence regions encompassing the true value (or, 1 -estimated error rate) across increasingly larger confidence levels. The x-axis corresponds to a userdefined confidence level, and the y-axis to the fraction of instances in the test set whose true value lies within the predicted confidence regions. It can be seen that the fraction of instances whose true value is within the predicted confidence interval (y-axis) is correlated with the confidence level, and hence this represents a 'well-calibrated' predictor in the context of Conformal Prediction, which can be used to assign the trust placed in future predictions of the model. (b) Example of a Regression Conformal Predictor that is not well-calibrated (adapted from 41 ). It can be seen that the fraction of instances whose true value is within the predicted confidence interval (y-axis) is not correlated with the confidence level. conformity measure 40 . Hence, Conformal Prediction is a technique that permits to compute wellcalibrated and easy-to-interpret errors in prediction for both balanced and imbalanced data sets, as we discuss more in depth below, at minimal computational cost 44 .
The first part of this review provides an overview of the design and advantages of the Conformal Prediction implementations used in drug discovery settings to date. The second part revisits the molecular modelling studies where Conformal Prediction played a key role in either estimating the reliability of individual predictions or in guiding prospective screening experiments. Finally, we discuss the current limitations of Conformal Prediction and offer a perspective on future directions. In regression, the efficiency of a CP refers to the average size of the predicted confidence intervals. The tighter the intervals the more efficient a conformal predictor is. In the case of classification, efficiency refers to the fraction of single-class predictions that are correct.
Confidence level (CL)
The confidence level is defined by the modeler and refers to the minimum fraction of predictions whose true value will lie within the predicted confidence region, in the case of regression, and the fraction of instances whose true class will be among the set of predicted classes.
Error rate
The error rate refers to the fraction of instances whose true value lies outside the predicted confidence regions. If a CP is well-calibrated, the error rate should not be larger than 1-CL (see also Figure 1 ). Nonconformity measure Function used to evaluate the relatedness or conformity of new instances to those used for model training. 
Conformal Prediction Modalities Commonly Used in Computer-Aided Drug Design
In this section, we will describe the most widely used Conformal Prediction modalities in the drug discovery literature, and the steps required to generate them (see a general pipeline below) using a real-world bioactivity data set. We refer the reader to the work of Vovk et al. 32, 36, 37 for further details about the mathematical foundations underlying the Conformal Prediction framework, and to Norinder et al. 32 and Eklund et al. 44 for an introduction focused on the application of Conformal Prediction to virtual screening.
The Conformal Prediction implementations we will discuss follow the same core steps, namely:
1. Choosing a non-conformity measure to evaluate the non-conformity between the training and the test instances; 2. Training the machine learning model of choice, and evaluate the non-conformity values for the training examples; 3. Applying the trained model to the test or external set instances; 4. For each test set instance, evaluating its non-conformity with respect to the training data using the same non-conformity measure used in step 1: the higher the conformity of the new instance, the higher the reliability of the prediction; 5. Identifying reliable predictions given the user-defined significance and confidence levels; and 6. Evaluating the validity and efficiency of the generated Conformal Predictor.
Inductive Conformal Prediction (ICP) Inductive Conformal Prediction for Classification
To generate an ICP model, the data available for training is divided into (see Figure 2 ) (i) a training set (also termed proper training set 82 ), consisting of e.g., 70% of the data, (ii) a calibration set, encompassing e.g., 15% of the data, and (iii) a test set, consisting of the remaining datapoints. Both the proper training and calibration sets are used for training, whereas the test set is used to evaluate the predictive power of the models, as well as the validity and efficiency of the Conformal Predictors generated. (Table 1) .
A machine learning model is firstly trained on the proper training set (step 1 in Figure 2 ), and subsequently applied to predict the activity label for the instances in the calibration set (step 2 in Figure 2 ; for illustration purposes, we here consider that the underlying model is always a RF model unless otherwise stated). The true and predicted class labels for the calibration set instances serve to compute non-conformity scores using the non-conformity measure of choice, for instance, the fraction of Trees from a Random Forest Model voting for the class receiving most votes. The non-conformity score serves to quantify the non-conformity (or 'strangeness') of a new instance with respect to those used for training. Predictions for which most of the Trees in the Random Forest predict the same label are more reliable, and hence, have a higher nonconformity score than cases where the algorithm does not delineate both classes correctly; that is, both classes are predicted to be equally likely. The model is then applied to the test set and the fraction of Trees voting for the most voted class is recorded for each instance (step 3 in Figure 2 ). Finally, the P value for each test set instance is calculated as the fraction of instances in the calibration set with a non-conformity score equal or smaller than the nonconformity score for the instance under consideration. Thus, the P value represents the ranking of the non- conformity score for a new instance with respect to the non-conformity score list generated for the calibration set. The P value is then compared against the significance level, e, which is defined as 1 -CL. A prediction is considered reliable if the P value is higher than e. Note that the concept of P value used here is not equivalent to traditional P values used in statistics.
To illustrate this approach using real-world data, we collected pIC50 data for 5,207 compounds against the Human ether-a-go-go-related gene (hERG) potassium channel from the ChEMBL database version 23 9 . To generate a RF binary classification model we considered as active those compounds with a pIC50 value ³ 7 (n=332), and assigned the remaining compounds to the inactive class (n=4,875). The resulting data set had an imbalance in the ratio of active to inactive compounds of ~1:15. This data set was previously used to benchmark bioactivity modelling pipelines 83 , and is publicly available at:
https://github.com/isidroc/kekulescope/tree/master/datasets. Next, we calculated circular
Morgan fingerprints for all compounds using RDkit (release version 2013.03.02) with a radius of 2 and a fingerprint length of 1,024 bits. To generate an RF-based Inductive Conformal Predictor using a confidence level of 80% we followed the steps described in Figure 2 , with the exception that 60% of the data was used as test set in this case for illustration purposes to ensure that we had enough active compounds to compute validity estimates for the resulting Conformal
Predictors.
We report in Figure 3 the distribution of non-conformity scores (a) for the calibration and (b) test sets. Unreliable predictions on the test set (shown in red in Figure 3b ) are those whose nonconformity value is smaller or equal than the 80 th percentile of the list of non-conformity scores for the calibration set, indicated by the cross in Figure 3a , and by the black arrow in Figure 3a .
As stated above, the mathematical validity of CP guarantees that at least 80% of the predictions considered reliable will be correct. However, the validity is only guaranteed globally, meaning that the error rate for the reliable predictions (i.e., fraction of predictions that are incorrect) might be different across classes, as some classes are harder to predict than others. This is a major issue when modelling imbalanced data, as the error rate will be higher for, usually, the minority class 39 . In fact, in the hERG data set modeled here we observe that most active compounds are predicted as unreliable (Figure 3c ). Therefore, although 80% of the predictions flagged as reliable are correct (global validity), the percentage of active compounds with a reliable prediction is only 24% (28/115; Table 3 and Figure 3) , and more importantly, only 14% of the active compounds with a reliable prediction are correctly predicted as active ( Table 3 . Confusion matrix for the classification model trained on the hERG data set, showing that the distribution of reliable and unreliable predictions across classes is not even, and in line with the data distribution in the training data set (which is biased towards the inactive class). The results correspond to the prediction for the test set molecules, and the reliability assignment now allows for the selection of molecules with the desired confidence for subsequent steps of e.g., experimental testing. See also Figure 3 . Figure 3 Generation of an Inductive Conformal Predictor using the bioactivity data stored in ChEMBL version 23 for target hERG. The instances in the data set were assigned to the active or inactive class using a cut-off value of 7 pIC50 units to generate a highly-imbalanced data set (active to inactive ratio of 1:15). (a) Non-conformity values for the instances in the calibration set. In this example the non-conformity function chosen corresponds to the fraction of Trees voting for the most voted class. For instance, if 85% of the trees in the RF model vote for the active class, the non-conformity score would be 0.85. The sorted list of non-conformity scores serves to calculate αCL. (b) The nonconformity scores are calculated for each instance in the test set. Those predictions with α values equal or greater than αCL are considered reliable. In this case, unreliable predictions are those for which roughly the same number of Trees in the RF model vote for each class. In both (a) and (b) the instances in the x-axis have been sorted according to their non-conformity score (y-axis). (c) Distribution of inactive and active compounds in the set of reliable (left) and unreliable (right) predictions. The figure shows that most of the reliable predictions correspond to inactive compounds, which are easier to model given the imbalance in the data. Therefore, although at least 80% of the predictions considered reliable are correct, most of the active compounds are assigned an unreliable prediction (Table 3) , allowing the modeler to focus on those predictions with the desired confidence in turn.
• Index for instances in the calibration set Fraction of trees voting for the most voted class The lack of validity for each class (or local validity) fostered the development of Inductive 39, 84 , which permits to calibrate the error rates in a class-specific manner.
Mondrian Conformal Prediction

Handling Imbalanced Datasets: Mondrian Conformal Prediction (MCP)
In MCP each class (e.g., active and inactive) is treated separately, and the confidence in the assignment of a given instance to the classes considered is evaluated independently. That is, a list of non-conformity scores is generated for each class using the predictions for the calibration set ( Figure 4) . Thus, in a binary classification setting a compound might be classified as "active", "inactive", both active and inactive (class "both"), or not assigned to either of them (class "null"
or "empty"). -Step 3. Applying the model trained in step 1 to the test set, and for each instance compute the fraction of trees voting for each class; and -Step 4. For each instance in the test set computing a P value for each class. The P value is the fraction of cases in the corresponding Mondrian class list calculated using the calibration set predictions in Step 3 smaller than the vote fraction for that class. If the P value for a given class is above the significance level, ɛ, the test set instance under consideration is predicted to belong to that category. Compounds are assigned to all categories for which the P value is greater or equal than ɛ.
Hence, a given compound may be predicted as "active", "inactive". However, it can also be predicted as "both" in cases when the model does not have enough predictive power to discriminate between classes, or "null" in cases when the instance is outside the applicability domain of the model. Thus, MCP gives an unbiased estimate of the reliability of the predictions given the training data on a class-specific manner. While this behavior might seem counterintuitive, it is actually a straightforward consequence of the types of data and evidence that might be present in a given training dataset -for example, if there are two closely related molecules to the one a prediction is made for, one of which is active and one of which is inactive, then there is evidence for both classes, and (at a given confidence level) none can be chosen over another. Likewise, if no evidence for either class is present in a data set (such as for a chemically very novel molecule), then no prediction either way can be made in practice.
This aspect of modelling data is often neglected in other modelling approaches, which forces a decision onto the model, hence resulting in single labels which are often more easy to deal with in practice, but which neither consider the confidence of a prediction properly, nor the underlying evidence of class membership present in the available data.
The significance level, ɛ, indicates the maximum fraction of predictions that are incorrect. In MCP this fraction is guaranteed for each class, which means that at least 1-ɛ of the predictions for the minority class will be correct. This is of utmost importance in drug discovery, where for example inactive molecules usually outnumber actives by several orders of magnitude.
Likewise, for models in later stages of drug discovery, being able to anticipate for which areas of chemical space no predictions can be made (and to assign a confidence to the remainder) is as important as being able to model the data in the first place.
It is important to note that increasing the confidence level generally reduces efficiency, defined as the single-label prediction rate. In fact, the number of null class predictions is anticorrelated with the confidence level, whereas the number of predictions predicted to belong to both categories positively correlates with the significance level 32 . This relationship between confidence level and one-class assignments is illustrated in Figure 5 , where we show the results generated using a MCP trained on the hERG data set described above (see also Table 4 and Figure 3 ). Hence in practice the modeler needs to make choices as to which confidence level and efficiency is desired in a particular case, which involves a certain amount of subjective choice as well.
Since the introduction of MCP in the chemical-structure activity modelling community 32 , the advantages of MCP have been showcased in a number of applications, mostly to perform classification tasks using imbalanced data sets, which is the situation MCP sets out to address.
Norinder et al. 32 applied MCP to binary classification of compounds and showed that the number of null predictions and the confidence level are inversely correlated, whereas the opposite is observed for the both category ( Figure 6 ). Therefore, increasing the confidence might lead to assign molecules to the both category that are already assigned only to the correct category at a lower confidence level, underlining that this parameter represents a trade-off between multiple factors, and that a higher confidence level is not always the better choice ( Figure 6 ). By modelling Ames mutagenicity data using Mondrian ICP Norinder et al. 6 showed that the inconsistency across data sets from different sources seems to prevent the generation of valid conformal predictors, likely in this case due to inconsistencies in categorizing moderately mutagenic compounds as mutagenic or non-mutagenic, which highlights the importance of evaluating data consistency prior to modelling [85] [86] [87] . This can also be seen as a useful feature of CP algorithms, where the model itself is able to detect how consistent training data is which it is trained with, in the same way it is able to assign a confidence level to the output values. Norinder et al. 4 also implemented Inductive MCP using Random Forest as the underlying algorithm to model the mutagenicity of 936 primary aromatic amines (630 mutagenic and 306 nonmutagenic) using Leadscope fingerprints 88 where it was found that models were valid for both classes. A recent large-scale comparison of QSAR and MCP models for ligandtarget prediction using in vitro activity data for 550 human protein targets extracted from ChEMBL found that the predictive power of both approaches (in terms of correct classification rate) is overall similar for 92% of the targets considered at a confidence level of 80% 78 . The usefulness of MCP as a robust method to determine the applicability domain of predictive models for regulatory purposes has been shown by Norinder et al. 39 using carcinogenicity and mutagenicity data. Overall, these studies showcase the versatility of MCP to handle imbalanced It can be seen that the fraction of instances whose try value is among the set predicted labels is ~0.8 for both categories, which corrresponds to the selected confidence level in this case. The instances in a, b, d, and e have been sorted in increasing order according to the value of their associated non-conformity score (y-axis).
• Index for ACTIVE instances in the training set Fraction of trees voting for INACTIVE class for INACTIVE compounds data sets. However, holding out the calibration set to generate the list of non-conformity scores hampers the use of all available labelled data for model training. Therefore, several flavours of CP designed to use all available data have been developed, which we will revisit later in this review (see section 'Conformal Prediction Using All Labelled Data for Learning'). Table 4 . Performance of the MCP model trained for the hERG data set. It can be seen that the predictions are globally and locally valid, i.e. across the model and also for individual classes. 
ICP for Regression
The underlying principles to generate Inductive Conformal Predictors for regression tasks are similar to those described above for classification models. Firstly, a model is trained on the proper training set (step 1 in Figure 7) . Subsequently, the model is applied to the calibration set (step 2 in Figure 7 ). In the case RF-based ICP models the predicted value for each instance in the validation set, " #, is then calculated as the average across the Trees in the Random Forest, and the standard deviation of these, $, is used as a measurement of the prediction's uncertainty 89 . Scaling the absolute error in prediction using a measure of confidence about each prediction (e.g., the bagged variance 29 ) serves to generate tighter predictions for those prediction that are deemed more reliable 90 . Note that without this scaling all predictions for the new molecules would be of the same size (Equation 1).
The residuals and the standard deviation across the forest are used to generate a list of nonconformity scores for the calibration set as follows:
where " 0 is the i th instance in the validation set, and " 4 5 and $ 0 are the average and the standard deviation of the predicted activities for the i th instance across the forest, respectively. The resulting list of non-conformity scores, 9, is sorted in increasing order, and the percentile corresponding to the confidence level considered is selected, e.g., the 80 th percentile for a confidence level of 0.80 (α ;< ). Next (step 4 in Figure 7 ), the standard deviation across the forest is used to calculate confidence regions for the data points in the test set as follows (step 4 in Figure 1 ):
Where " J is the j th instance in the test set, " G 5 and $ J are the average and the standard deviation of the predicted activities for the j th instance across the forest, respectively, and α QR is the nonconformity score for the selected confidence level. increase the size of very small intervals not reflecting the inherent uncertainty of bioactivity measurements [85] [86] [87] 91 .
A number of the Conformal Predictors reported in the literature applied to regression tasks use RF models as the underlying algorithm (Table 2) , and employ the standard deviation across base learners to scale the residuals and compute non-conformity scores 40, 92 ( Equation 1), a choice supported by comparative analysis of non-conformity measures 40 . RF models are widely used in Conformal Prediction because the generation of an ensemble comes at no extra computational cost 15, 32 , the training can be parallelized, and the performance is stable across parameter values, thus requiring little parameter tuning. The variance across base learners (i.e., the bagged variance across the trees in RF models) conveys a predictive signal to quantify the uncertainty of individual predictions, as the average RMSE on the test set increases with the variance among predictions 22, 29 . However, one should note that this numerical Pearson correlation between variance and prediction error is much weaker than the inflated correlation obtained by binning the test compounds on the basis of the predicted variance 22, 29, 93 , which in practice means that the size of the confidence regions calculated using non-conformity measures based on the bagged variance will not be strongly correlated with the unsigned error in prediction. In other words, the average RMSE on the test set is correlated with the size of the confidence interval computed using Conformal Predictors because, on average (but not in every individual case) the larger the variance across the ensemble, the larger the predicted confidence region will be (Equation 2). Other studies have used a second machine learning model, termed error model, to predict errors in prediction to identify which predictions are less reliable in a similar manner as the standard deviation across the forest is used in RF-based conformal predictors (Equation 1 ). This is achieved by training a model on the same chemical descriptors used to train a point prediction model to predict the error in prediction during crossvalidation 92 or for the calibration set instances 32 . In other cases other metrics are used as covariates 31, 94 , or linear methods 95 . Overall, this approach has been shown to deliver less efficient Conformal Predictors as compared to those generated using the bagged variance when modelling QSAR data sets 40 .
Inductive CP has been applied to diverse regression tasks (Table 2) , including proteochemometric modelling of PARP inhibitors 46 and the prediction of patterns of growth inhibition across cancer cell line panels 92 . However, most studies using CP for regression tasks have implemented CP modalities designed to use all available training data for learning, which we discuss in the next section.
Conformal Prediction Using All Labelled Data for Learning
A common disadvantage to all the CP modalities revisited so far is that not all data available for training are used for model fitting, as the calibration set needs to be kept aside to generate the list of non-conformity scores (Figures 2 and 4) . However, it would be desirable to use all available data during training to increase the predictive power of the resulting models, in particular in cases where few data points are available for a given class or a particular region of the bioactivity range considered. Several CP modalities have been developed to date to solve this issue 96, 97 . We here revisit the two most widely used in drug discovery in both regression and classification tasks (Table 2) , namely Aggregated Conformal Prediction (ACP) 98, 99 and Cross
Conformal Prediction (CCP) 96 .
-
Aggregated Conformal Prediction (ACP)
The ACP approach consists of generating a collection of usually 10-100 43, 56, 80 Inductive
Conformal Predictors (e.g., Inductive MCP), each of them trained on the same training data but with random assignments of training set instances to the proper training and calibration sets.
Thus, the instances assigned to the calibration and proper training sets are different for each model, resulting in reduced variance for the predicted confidence regions, and increased efficiency 98 . In the case of classification, each model is applied to the test (or external) set instances, and the P values computed with each of these models are recorded for each instance (and for each class in the case of MCP). The final P value is calculated as e.g., the median P value and each instance is assigned to those classes for which the median P value is higher than the significance level. In the case of regression, the final confidence interval for each test set instance is also a function of the set of confidence intervals predicted by each of the set of models trained, such as half the difference between the median of the maximum and minimum predicted values 61 .
ACP has been applied in diverse drug discovery tasks (Table 2) , including Ames mutagenicity prediction 67 , multi-task learning using matrix factorization 80 , modelling of compound binding to the estrogen and androgen receptors 54 , and virtual screening of TRPV1 agonists 100 . Lindh et al. 61 generated Aggregated Conformal Predictors to model the permeation rate through the human skin of 211 chemical compounds 60 . Whereas the predictive power did not increase with respect to previous models reported for the same data set, CP added the advantage of providing predictions as confidence regions, and using all available data for training, which was crucial in this particular case due to the limited size of the training data. ACP has also proved versatile to model highly imbalanced data sets. For instance, Svensson et al. 70 modelled 12
highly-imbalanced bioactivity data sets from PubChem using ACP and a cost-gain function taking into account screening costs and the gain of finding active hits. ACP was also shown to accurately model highly-imbalanced cytotoxicity data sets from PubChem 62 , with only 0.8% of cytotoxic compounds, showing an external validation set a sensitivity of 74% and a specificity of 65% for the single-label predictions at a confidence level of 80%. Lastly, ACP has also been applied in two iterative screening studies, where Conformal Prediction followed molecular docking in order to prioritize compounds for experimental testing 56, 101 . Overall ACP has been found to reduce the variance and increase the efficiency of the predicted confidence intervals, while also permitting the use of all available data for training.
Cross-Conformal Prediction (CCP)
In CCP the training data set is divided into k non-overlapping sets, in a similar manner as performed in k-fold cross validation. Next, k ICP models are trained, each time using a different set as calibration set, thus permitting the use of all labelled data for training. For each instance in the test set k P values are generated, whose e.g., mean value can be used as the output P value. The output P values are compared against the significance level to assign a class to the test instances (or classes in the case of Mondrian CCP). To date, Mondrian CCP has been mostly applied to model imbalanced bioactivity data sets ( of CCP prediction, which permits to obtain valid and efficient conformal predictors while using all available labelled data for training.
Conformal Prediction Methods for Deep Learning
Deep learning is currently applied in many tasks of the drug discovery process, a trend that is only expected to rise in the next years 103, 104 81 , that consists of training a network using dropout 106 . Next, the network is applied to compute N forward passes using dropout as well. As in the case of Deep Confidence, the variability across these forward passes is used to scale the absolute errors in prediction. Overall, it could be shown that both Deep Confidence and TestTime Dropout Conformal Prediction deliver well-calibrated predicted confidence intervals that, in addition, span a narrower range of values than those computed using RF-based models.
Open-Source Implementations of Conformal Prediction
The increased adoption of CP in early-stage drug discovery settings has fostered the implementation of several CP modalities in open-source software libraries in the R programming language and Python, which are widely used programming languages in medicinal chemistry applications 107, 108 . The availability of predictive modelling packages in both R (e.g., caret 109 114, 115 .
Current Limitations of Conformal Prediction and Future Perspectives
While Conformal Prediction, as described above, is able to assign confidence to predictions within a computationally efficient framework some areas of ongoing methodological research certainly remain. A major issue in CP applied to regression is the low efficiency of most CP models, which leads to the predicted confidence regions to span multiple e.g., pIC50 units. Such large intervals are not informative and thus hamper the practical usefulness of CP. Substantial efforts in the community have been invested in investigating and developing non-conformity functions to reduce the size of the predicted confidence regions 40, 63, 90, 116 . However, future research will be needed to improve current non-conformity measures in order to, ultimately, generate errors in prediction comparable to the uncertainty of the data [85] [86] [87] . In classification settings, a common problem faced is the substantial increase of instances predicted to belong to multiple categories as the confidence level is increased 32, 78 . This problem is analogous to the lack of efficiency of regression models. As in the regression case, the development of improved non-conformity measures 57, 80 will be needed to improve the efficiency of classification CP models. Another major shortcoming of the predicted confidence regions in the case of regression is the poor correlation between the absolute error in prediction (i.e., unsigned error) and the size of the confidence interval. This is due to the fact that error models used in nonconformity measures e.g., the bagged variance, do not predict accurately the error in prediction 89, 94 . Thus, large confidence intervals are obtained for accurate predictions and vice versa. Using alternative methods to the bagged variance to compute nonconformity scores, such as quantitative metrics developed in the QSAR arena to estimate the applicability domain of the models 26 , might alleviate this issue. Similarly, algorithms other than the most widely used to date (RF, SVM and neural networks; Table 2 ) might also be considered in drug discovery applications as alternative methods to generate more efficient Conformal Predictors 80, 90 .
Today, Mondrian CP modalities, including Mondrian ACP and CCP, have become the standard approach to model imbalanced data sets when using Conformal Prediction. However, also the data sets themselves which are used to model compound activity on a continuous scale are generally biased, which leads to an uneven coverage of the chemical space across the bioactivity range considered, and hence variable errors rates across it 94 . Therefore, the development of methods to handle the uneven distribution of datapoints across the bioactivity range considered in regression models would be useful to remove biases from models, and hence guarantee that the validity and efficiency of the predicted confidence intervals are even across the bioactivity range modelled, and not only across the entire bioactivity range.
The integration of predictions generated by independent conformal predictors is a current area of intense research, similar to ensemble approaches in other domains. Toccaceli et al. 117 recently introduced a method to integrate ICP models trained on different underlying algorithms.
Notably, the combined models outperformed base learners (linear SVM, Gradient Boosted
Trees, and k-Nearest Neighbours) on an IDH1 bioactivity data set extracted from the ExCAPE database 8 . An alternative approach to integrate CP models, applicable to both classification and regression models, is Synergy CP 97 , which permits the aggregation of CP models trained in parallel on subsets of the training data into valid and efficient Conformal Predictors. Overall, these studies represent innovative solutions that will permit not only performance improvements, but also the exploitation for drug discovery of (proprietary) data dispersed across companies and institutions in distributed environments.
As stated above, the validity of CP is only guaranteed if the randomness or exchangeability assumptions hold. This assumption is however not usually verified in practice, and it is only assumed that the training data and the molecules to which CP models are applied are drawn from the same distribution. It is of course unlikely that the chemical space covered in the training data of virtual screening models, even if these encompass thousands of molecules, is entirely representative of the entire chemical space already comprised in academic and commercial chemical libraries, or amenable to chemical synthesis. In fact, the authors recently showed using iterative virtual screening experiments that breaching the randomness assumption leads to useless conformal predictors 41 . This issue is of particular relevance given that many of the CP reported to date are based on few hundred datapoints (Table 2) . Therefore, further development of methods to determine to what extent the randomness or exchangeability assumptions hold would be useful in practice to make informed decisions on the applicability of the developed CP models on the basis of the difference between the training data and those molecules to which the models are applied.
